Avrobio Plots Comeback With Early Data From Gaucher’s Gene Therapy

Sees Bluebird Success As Creating Pathway

 
• By Andrew McConaghie
  
Avrobio
Avrobio is looking to revive its fortunes by developing a Gaucher's gene therapy. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip